Edit

angelMD

http://www.angelmd.co/

Last activity: 11.01.2019

Active

Based in Denver, Colorado, AngelMD is a healthcare-focused investing platform that connects leading healthcare startups from all over the world with investors, physicians, industry executives and private capital to create a more efficient path from investment to exit while de-risking investments in the process, leading to better outcomes.

We welcome all healthcare startups to create a profile on our site. Even if you are not currently looking for funding, create a profile to be connected to industry thought leaders and valuable resources as you grow your business.

Portfolio

Mentions

Location: United States, Colorado, City and County of Denver

Employees: 11-50

Founded date: 2013

Investment Type: Venture Capital

Portfolio 1

Date	Name	Website	Total Raised	Location
28.08.2017	Access Vas...	accessvascularinc.com	$51.7M	United Sta...

Mentions in press and media 17

Date	Title	Description
11.01.2019	5 Houston startups beginning 2019 with new capital	Finding growing Houston startups is as easy as following the money, and a few local companies are starting 2019 strong with a recent round of funding closed. InnovationMap has rounded up a few recent raises to highlight heading into the new...
21.09.2018	Neumentum Raises Funding from AngelMD	Neumentum, Inc., a California-based company that is developing and plans to commercialize products to treat pain, without the risks of abuse, misuse and diversion seen with opioid analgesics, raised funding from AngelMD, an investment and n...
25.05.2018	Sensulin Raises Undisclosed Series B Funding Round	Sensulin, an Oklahoma City, Ok-based biotechnology company, raised an undisclosed Series B funding round. A group of physician and investor members of AngelMD participated in the round. The company intends to use the funds to conduct first-...
28.11.2017	Fibralign Raises Funding from Investor Syndicate of AngelMD	Fibralign, Inc., a Union City CA-based maker of therapeutic medical devices for regenerative medicine, raised funding from a syndicate of AngelMD, an investment and networking platform connecting innovative medical startups, physicians, inv...
30.10.2017	Investors Navigate Promise, Hype, in Funding A.I. for Healthcare	Share Share on Facebook Share on Twitter LinkedIn Email Reprints From a venture investment perspective, digital health is having a record year—one that has come as something of a surprise against the backdrop of federal policy uncertainty. ...
28.08.2017	Access Vascular Raises $3.7 Million Funding from angelMD	Access Vascular, a medical device company developing innovative venous access devices that eliminate thrombotic risk, today announced $3.7 million in funding from individual investors and angelMD, an investment platform and marketplace conn...
28.08.2017	Access Vascular Secures $3.7M In Financing	Access Vascular, a Bedford, MA-based medical device company developing innovative venous access devices that eliminate thrombotic risk, raised $3.7m in funding. Backers included individual investors and angelMD, an investment platform and m...
05.08.2017	angelMD Announces Investment Syndicate for Access Vascular	angelMD announced an investment syndicate with Access Vascular Inc., a company developing innovative venous access devices. Arun Jagannathan, MD and Orrin Ailloni-Charas, MD, MBA, are leading the company’s first syndicate with angelMD. Acce...
05.08.2017	angelMD Announces Investment Syndicate for Access Vascular	angelMD announced an investment syndicate with Access Vascular Inc., a company developing innovative venous access devices. Arun Jagannathan, MD and Orrin Ailloni-Charas, MD, MBA, are leading the company’s first syndicate with angelMD. Acce...
06.04.2016	Qool Therapeutics Closes Seed Funding Round	Qool Therapeutics, Inc., a Menlo Park, CA-based developer of non-invasive therapeutic hypothermia device for targeted temperature management and exercise recovery, closed a seed funding round of undisclosed amount. An investor syndicate of ...
30.10.2014	Stanford spinout developing surgical site wound care snags $6M	That’s why Prescient’s first working to roll out products for abdominal and laparoscopic surgeries, with plans to expand into vascular, orthopedic and endocrine surgeries. The company’s led by Coe, a 10-year vet of the device industry who c...
13.08.2014	Niveus Medical raising $3.6 million for its muscle atrophy-treating device	Its device has received marketing clearance from the FDA, Niveus said. The company asserts a case for its technology: In the US, there are 6M annual admissions to the ICU. Niveus will initially target the 1.8 million patients who have an IC...
03.04.2014	Medical Marketing Economics Invests in angelMD	angelMD, a medical-focused equity crowdfunding company, has shared that Oxford, Mississippi-based Medical Marketing Economics (MME) has made a strategic investment in angelMD and formed a partnership. MME clients cover a wide spectrum of gr...
14.03.2014	Kineta Receives Investment from angelMD	Kineta, Inc., a Seattle, WA-based biotechnology company, received an investment from angelMD and its physician-led investor network. The amount of the transaction was not disclosed. Led by Charles Magness, PhD, Founder and CEO, Kineta has a...
14.02.2014	angelMD Equity Crowdfunding Platform Boosts Staff	angelMD, a private equity firm plus equity crowdfunding platform, has recently added to staff having announced the addition of 3 leading clinicians to its senior management team. Based in San Francisco, California and Seattle, Washington, a...
-	Niveus Medical raising $3.6 million for its muscle atrophy-treating device	Without stimulation and movement, a patient’s muscles can slowly waste away – a major concern among the immobile patient set. Palo Alto medtech startup Niveus Medical has developed a device that uses electrodes to shock a muscle back to liv...
-	Stanford spinout developing surgical site wound care snags $6M	Prescient Surgical, a Bay Area wound care startup that aims to reduce surgical site infection, has raised about $6 million, according to a regulatory filing. The company’s staying pretty vague about the technology’s specifics, but president...

angelMD

Portfolio 1

Mentions in press and media 17

Reviews 0